FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209750482> ?p ?o ?g. }

• W3209750482 endingPage "1082" @default.
• W3209750482 startingPage "1082" @default.
• W3209750482 abstract "Frequent relapses and therapeutic resistance make the management of glioblastoma (GBM, grade IV glioma), extremely difficult. Therefore, it is necessary to develop new pharmacological compounds to be used as a single treatment or in combination with current therapies in order to improve their effectiveness and reduce cytotoxicity for non-tumor cells. SFX-01 is a fully synthetic and stabilized pharmaceutical product containing the α-cyclodextrin that delivers the active compound 1-isothiocyanato-4-methyl-sulfinylbutane (SFN) and maintains biological activities of SFN. In this study, we verified whether SFX-01 was active in GBM preclinical models. Our data demonstrate that SFX-01 reduced cell proliferation and increased cell death in GBM cell lines and patient-derived glioma initiating cells (GICs) with a stem cell phenotype. The antiproliferative effects of SFX-01 were associated with a reduction in the stemness of GICs and reversion of neural-to-mesenchymal trans-differentiation (PMT) closely related to epithelial-to-mesenchymal trans-differentiation (EMT) of epithelial tumors. Commonly, PMT reversion decreases the invasive capacity of tumor cells and increases the sensitivity to pharmacological and instrumental therapies. SFX-01 induced caspase-dependent apoptosis, through both mitochondrion-mediated intrinsic and death-receptor-associated extrinsic pathways. Here, we demonstrate the involvement of reactive oxygen species (ROS) through mediating the reduction in the activity of essential molecular pathways, such as PI3K/Akt/mTOR, ERK, and STAT-3. SFX-01 also reduced the in vivo tumor growth of subcutaneous xenografts and increased the disease-free survival (DFS) and overall survival (OS), when tested in orthotopic intracranial GBM models. These effects were associated with reduced expression of HIF1α which, in turn, down-regulates neo-angiogenesis. So, SFX-01 may have potent anti-glioma effects, regulating important aspects of the biology of this neoplasia, such as hypoxia, stemness, and EMT reversion, which are commonly activated in this neoplasia and are responsible for therapeutic resistance and glioma recurrence. SFX-01 deserves to be considered as an emerging anticancer agent for the treatment of GBM. The possible radio- and chemo sensitization potential of SFX-01 should also be evaluated in further preclinical and clinical studies." @default.
• W3209750482 created "2021-11-08" @default.
• W3209750482 creator A5002876711 @default.
• W3209750482 creator A5003059032 @default.
• W3209750482 creator A5008951735 @default.
• W3209750482 creator A5016703211 @default.
• W3209750482 creator A5016735563 @default.
• W3209750482 creator A5036040057 @default.
• W3209750482 creator A5039243219 @default.
• W3209750482 creator A5045386352 @default.
• W3209750482 creator A5047763791 @default.
• W3209750482 creator A5047952766 @default.
• W3209750482 creator A5051278445 @default.
• W3209750482 creator A5073735460 @default.
• W3209750482 creator A5076187874 @default.
• W3209750482 date "2021-10-26" @default.
• W3209750482 modified "2023-09-26" @default.
• W3209750482 title "Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma" @default.
• W3209750482 cites W1491781433 @default.
• W3209750482 cites W1937142939 @default.
• W3209750482 cites W1976578289 @default.
• W3209750482 cites W1977219317 @default.
• W3209750482 cites W1993720954 @default.
• W3209750482 cites W1998941426 @default.
• W3209750482 cites W2002015567 @default.
• W3209750482 cites W2025126379 @default.
• W3209750482 cites W2027823401 @default.
• W3209750482 cites W2029728492 @default.
• W3209750482 cites W2033279684 @default.
• W3209750482 cites W2054796618 @default.
• W3209750482 cites W2055293030 @default.
• W3209750482 cites W2056056906 @default.
• W3209750482 cites W2063592445 @default.
• W3209750482 cites W2076500925 @default.
• W3209750482 cites W2094369130 @default.
• W3209750482 cites W2105618861 @default.
• W3209750482 cites W2128083719 @default.
• W3209750482 cites W2133207578 @default.
• W3209750482 cites W2140382280 @default.
• W3209750482 cites W2156179144 @default.
• W3209750482 cites W2157607726 @default.
• W3209750482 cites W2161708429 @default.
• W3209750482 cites W2179782203 @default.
• W3209750482 cites W2392045628 @default.
• W3209750482 cites W2525623098 @default.
• W3209750482 cites W2529857084 @default.
• W3209750482 cites W2530829140 @default.
• W3209750482 cites W2564096649 @default.
• W3209750482 cites W2568132954 @default.
• W3209750482 cites W2568391148 @default.
• W3209750482 cites W2617807734 @default.
• W3209750482 cites W2622821813 @default.
• W3209750482 cites W2730647935 @default.
• W3209750482 cites W2734818928 @default.
• W3209750482 cites W2774503599 @default.
• W3209750482 cites W2783020943 @default.
• W3209750482 cites W2791396154 @default.
• W3209750482 cites W2791658797 @default.
• W3209750482 cites W2791777845 @default.
• W3209750482 cites W2801112880 @default.
• W3209750482 cites W2804980023 @default.
• W3209750482 cites W2883931306 @default.
• W3209750482 cites W2896030446 @default.
• W3209750482 cites W2908680705 @default.
• W3209750482 cites W2910063346 @default.
• W3209750482 cites W2921754179 @default.
• W3209750482 cites W2944882638 @default.
• W3209750482 cites W2948685705 @default.
• W3209750482 cites W2977267327 @default.
• W3209750482 cites W2980534481 @default.
• W3209750482 cites W2999381561 @default.
• W3209750482 cites W3015821423 @default.
• W3209750482 cites W3021956547 @default.
• W3209750482 cites W3024542302 @default.
• W3209750482 cites W3025447533 @default.
• W3209750482 cites W3028112257 @default.
• W3209750482 cites W3046928762 @default.
• W3209750482 cites W3085743165 @default.
• W3209750482 cites W3086333549 @default.
• W3209750482 cites W3087818720 @default.
• W3209750482 cites W3090597480 @default.
• W3209750482 cites W3091840402 @default.
• W3209750482 cites W3092089536 @default.
• W3209750482 cites W3092669207 @default.
• W3209750482 cites W3097646670 @default.
• W3209750482 cites W3112558105 @default.
• W3209750482 cites W3129727855 @default.
• W3209750482 cites W3136307184 @default.
• W3209750482 cites W3149922590 @default.
• W3209750482 cites W3157674399 @default.
• W3209750482 cites W3157706781 @default.
• W3209750482 cites W3161056970 @default.
• W3209750482 cites W3167899726 @default.
• W3209750482 cites W3167994896 @default.
• W3209750482 cites W3174642402 @default.
• W3209750482 cites W3201052437 @default.
• W3209750482 cites W4252785935 @default.
• W3209750482 cites W4322384924 @default.

• next